Suppr超能文献

真性红细胞增多症所致微小病变病:一例报告

Minimal change disease caused by polycythemia vera: A case report.

作者信息

Xu Li, Lu Li-Li, Gao Jian-Dong

机构信息

Department of Nephrology, Shuguang Hospital Affiliated to the Shanghai University of Traditional Chinese Medicine, TCM Institute of Kidney Disease, Shanghai University of Traditional Chinese Medicine, Key Laboratory of Liver and Kidney Diseases (Shanghai University of Traditional Chinese Medicine), Ministry of Education, Shanghai Key Laboratory of Traditional Chinese Clinical Medicine (20DZ2272200), Shanghai 201203, China.

出版信息

World J Clin Cases. 2022 Nov 16;10(32):11993-11999. doi: 10.12998/wjcc.v10.i32.11993.

Abstract

BACKGROUND

Polycythemia vera (PV), often attributed to the JAK2 V617F mutation, is characterized by enhanced red blood cell counts in the peripheral blood. PV-associated renal disease is clinically rare; to date, there have been reports of other chronic kidney diseases related to PV, but no reports on PV-associated minimal change disease.

CASE SUMMARY

A 37-year-old man presented with proteinuria and high red blood cell count on January 4, 2021. The patient underwent bone marrow and renal biopsies, then was subsequently diagnosed with PV and minimal change in disease. Hydroxyurea was administered and proteinuria remission was achieved. The patient's last visit was on April 14, 2022.

CONCLUSION

We inferred that there may be a causal relationship between PV and minimal change disease.

摘要

背景

真性红细胞增多症(PV)通常归因于JAK2 V617F突变,其特征是外周血中红细胞计数增加。PV相关的肾脏疾病在临床上较为罕见;迄今为止,已有与PV相关的其他慢性肾脏疾病的报道,但尚无关于PV相关微小病变病的报道。

病例摘要

一名37岁男性于2021年1月4日出现蛋白尿和红细胞计数升高。患者接受了骨髓和肾脏活检,随后被诊断为PV和微小病变病。给予羟基脲治疗后蛋白尿缓解。患者最后一次就诊时间为2022年4月14日。

结论

我们推断PV与微小病变病之间可能存在因果关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a7f/9669836/942e93fd3997/WJCC-10-11993-g001.jpg

相似文献

1
Minimal change disease caused by polycythemia vera: A case report.
World J Clin Cases. 2022 Nov 16;10(32):11993-11999. doi: 10.12998/wjcc.v10.i32.11993.
4
Clinical and Pathological Features of Renal Presentations in Polycythemia Vera.
Am J Med Sci. 2022 Jan;363(1):33-41. doi: 10.1016/j.amjms.2021.10.009. Epub 2021 Oct 21.
5
Polycythemia vera: scientific advances and current practice.
Semin Hematol. 2005 Oct;42(4):206-20. doi: 10.1053/j.seminhematol.2005.08.003.
6
Somatic JAK-2 V617F Mutational Analysis in Polycythemia Rubra Vera: a Tertiary Care Center Experience.
Asian Pac J Cancer Prev. 2016;17(3):1053-5. doi: 10.7314/apjcp.2016.17.3.1053.
10
Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F.
PLoS One. 2006 Dec 20;1(1):e18. doi: 10.1371/journal.pone.0000018.

引用本文的文献

1
High altitude renal syndrome: four elements or one source?
Ren Fail. 2025 Dec;47(1):2482125. doi: 10.1080/0886022X.2025.2482125. Epub 2025 Apr 3.
2
A case report and literature review of IgA nephropathy presenting as nephrotic syndrome in polycythemia vera.
CEN Case Rep. 2024 Dec;13(6):495-498. doi: 10.1007/s13730-024-00879-x. Epub 2024 Apr 21.

本文引用的文献

2
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms.
Histopathology. 2021 Apr;78(5):738-748. doi: 10.1111/his.14282. Epub 2020 Dec 14.
3
Polycythemia Vera.
Curr Treat Options Oncol. 2018 Mar 7;19(2):12. doi: 10.1007/s11864-018-0529-x.
4
Minimal Change Disease.
Clin J Am Soc Nephrol. 2017 Feb 7;12(2):332-345. doi: 10.2215/CJN.05000516. Epub 2016 Dec 9.
5
Activation of the IL-2 Receptor in Podocytes: A Potential Mechanism for Podocyte Injury in Idiopathic Nephrotic Syndrome?
PLoS One. 2016 Jul 7;11(7):e0157907. doi: 10.1371/journal.pone.0157907. eCollection 2016.
6
Polycythemia vera associated with IgA nephropathy: A case report and literature review.
Exp Ther Med. 2015 Aug;10(2):555-560. doi: 10.3892/etm.2015.2572. Epub 2015 Jun 11.
7
Regulatory T cells and minimal change nephropathy: in the midst of a complex network.
Clin Exp Immunol. 2016 Feb;183(2):166-74. doi: 10.1111/cei.12675. Epub 2015 Oct 12.
8
Glomerular diseases associated with cancer, chemotherapy, and hematopoietic stem cell transplantation.
Adv Chronic Kidney Dis. 2014 Jan;21(1):48-55. doi: 10.1053/j.ackd.2013.08.003.
9
JAK2 mutation-related disease and thrombosis.
Semin Thromb Hemost. 2013 Jul;39(5):496-506. doi: 10.1055/s-0033-1343890. Epub 2013 Apr 30.
10
VEGF inhibition and renal thrombotic microangiopathy.
N Engl J Med. 2008 Mar 13;358(11):1129-36. doi: 10.1056/NEJMoa0707330.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验